NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 116 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,045 | -62.5% | 322,472 | -9.1% | 0.00% | -100.0% |
| Q2 2023 | $919,165 | -18.7% | 354,890 | +28.1% | 0.00% | 0.0% |
| Q1 2023 | $1,130,462 | +83.1% | 277,074 | +125.3% | 0.00% | 0.0% |
| Q4 2022 | $617,239 | -66.1% | 122,956 | -11.7% | 0.00% | -50.0% |
| Q3 2022 | $1,821,000 | -11.7% | 139,257 | -13.4% | 0.00% | 0.0% |
| Q2 2022 | $2,062,000 | +113.2% | 160,865 | +153.7% | 0.00% | +100.0% |
| Q1 2022 | $967,000 | -9.0% | 63,397 | +5.6% | 0.00% | 0.0% |
| Q4 2021 | $1,063,000 | +12.1% | 60,031 | +33.2% | 0.00% | 0.0% |
| Q3 2021 | $948,000 | +6.5% | 45,078 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $890,000 | +200.7% | 45,138 | +343.1% | 0.00% | – |
| Q1 2021 | $296,000 | – | 10,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |